Geriatric medicine

August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS28
Academic Journal
Presents an abstract of the research manuscript `MRI ventricular volume analysis as a method of differentiating DAT from AACD from normal controls: Preliminary results,' by T.A. Fitch, S. Murtha et al from the Sir Mortimer B. Davis-Jewish General Hospital. Magnetic resonance imaging (MRI); Dementia of Alzheimer's Type (DAT); Age associated cognitive decline (AACD).


Related Articles

  • Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia. Graham N L; Emery T; Hodges J R // Journal of Neurology, Neurosurgery & Psychiatry;Jan2004, Vol. 75 Issue 1, p61 

    BACKGROUND: There are inconsistencies in published reports regarding the profile of cognitive impairments in vascular dementia, and its differentiation from Alzheimer's disease. OBJECTIVES: To identify the overall profile of cognitive impairment in subcortical vascular dementia as compared with...

  • Evaluation Of Cognitive Impairment. Marks, Donald H. // Internet Journal of Health;2008, Vol. 8 Issue 1, p4 

    Mild cognitive impairment (MCI), a perceivable decrease in thought processes, primarily memory, occurs in individuals who are otherwise able to function in everyday activities. These patients have difficulty remembering the names of people, performing calculations, navigating in a mall parking...

  • Usefulness of Measurement of the Temporal Stem on Magnetic Resonance Imaging in the Diagnosis of Frontotemporal Dementia. Hayashida, Y.; Hirai, T.; Korogi, Y.; Kimura, T.; Ishizuka, K.; Kawanaka, K.; Yamura, M.; Kitajima, M.; IKushima, I.; Yamashita, Y. // Acta Radiologica;Jul2006, Vol. 47 Issue 6, p603 

    Purpose: To investigate whether measurements of brain structures on routine magnetic resonance (MR) images can be used to distinguish between normal subjects and patients with frontotemporal dementia (FTD) or Alzheimer's disease (AD). Material and Methods: MRI studies were performed on 30...

  • Correlation of Alzheimer-like Tau Hyperphosphorylation and fMRI Bold Intensity. Wang Xiao-Chuan; Hu Zheng-Hui; Fang Zheng-Yu; Feng Yue; Yang Yun-Huang; Wang Qun; Tang Xiao-Wei; Wu Yi-Gen; Wang Jian-Zhi // Current Alzheimer Research;Apr2004, Vol. 1 Issue 2, p143 

    To explore the correlation between cerebral functional alterations revealed by functional magnetic resonance imaging (fMRI) and Alzheimer disease- (AD)-like tau hyperphosphorylation, we injected bilaterally 2 �l each of 20 mM isoproterenol (IP), a PKA activator, or of saline as a vehicle...

  • Functional Connectivity in Elderly Controls and AD Patients Using Resting State fMRI: A Pilot Study. Rombouts, Serge; Scheltens, Philip // Current Alzheimer Research;Apr2005, Vol. 2 Issue 2, p115 

    Conventionally, Alzheimer's disease (AD) and other dementias are diagnosed using clinical assessment, neuropsychology and also structural neuroimaging, showing neuronal degeneration starting in the hippocampal regions. However, there is an increasing need for a new method that is more sensitive...

  • Early-onset Alzheimer's disease due to mutations of the presenilin-1 gene on chromosome 14: a 7-year follow-up of a patient with a mutation at codon 139. Hüll, Michael; Fiebich, Bernd L.; Dykierek, Petra; Schmidtke, Klaus; Nitzsche, Egbert; Orszagh, Miroslav; Deuschl, Günther; Moser, Ernst; Schumacher, Martin; Lücking, Carl; Berger, Mathias; Bauer, J. // European Archives of Psychiatry & Clinical Neuroscience;1998, Vol. 248 Issue 3, p123 

    Abstract Mutations in the presenilin-1 gene (PS-1 gene) on chromosome 14 have recently been identified as a cause of familial early-onset Alzheimer's disease (EOAD). To our knowledge, only two German EOAD patients with mutations in the PS-1 gene have been identified thus far. Herein we report...

  • Novel MRI techniques in the assessment of dementia. Teipel, Stefan J.; Meindl, Thomas; Grinberg, Lea; Heinsen, Helmut; Hampel, Harald // European Journal of Nuclear Medicine & Molecular Imaging;Mar2008 Supplement, Vol. 35, p58 

    Positive markers of Alzheimer’s disease (AD) have been established in MRI that may allow early detection of AD in at-risk groups. In the near future, these markers will be of high relevance for the selection of at-risk subjects in secondary preventive trials. We describe the methodology...

  • The relationship between the apolipoprotein E e4 allele and hippocampal magnetic resonance imaging volume in community-dwelling individuals with mild Alzheimer's disease. Walsh, Bernard; Slater, Stuart; Nair, Balakrishnan; Attia, John // Degenerative Neurological & Neuromuscular Disease;2013, Vol. 3, p11 

    Background: The degree of hippocampal magnetic resonance imaging (MRI) volume loss in Alzheimer's disease (AD) is commonly accepted as a marker of disease severity, yet remains expensive, unavailable, or not tolerated by many patients. Aim: To examine whether the presence of one or more...

  • Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham study. Seshadri, Sudha; DeStefano, Anita L.; Au, Rhoda; Massaro, Joseph M.; Beiser, Alexa S.; Kelly-Hayes, Margaret; Kase, Carlos S.; D'Agostino, Sr., Ralph B.; DeCarli, Charles; Atwood, Larry D.; Wolf, Philip A. // BMC Medical Genetics;2007 Supplement 1, Vol. 8, pS15 

    Background: Brain magnetic resonance imaging (MRI) and cognitive tests can identify heritable endophenotypes associated with an increased risk of developing stroke, dementia and Alzheimer's disease (AD). We conducted a genomewide association (GWA) and linkage analysis exploring the genetic basis...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics